CLPBF (Coloplast AS) Inventories, Finished Goods: $0 Mil (As of Mar. 2026)


CLPBF Coloplast AS CLPBF
72 GF Score
Price $60.47
GF Value $128.09
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Coloplast AS Inventories, Finished Goods?

Coloplast AS CLPBF +6.27% 72 Inventories, Finished Goods is $0 Mil as of Mar. 2026. GuruFocus rates CLPBF with a GF Score™ of 72/100 and a GF Value™ of $128.09 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Coloplast AS's quarterly finished goods declined from Sep. 2025 ($346 Mil) to Dec. 2025 ($0 Mil) but then stayed the same from Dec. 2025 ($0 Mil) to Mar. 2026 ($0 Mil).

Coloplast AS's annual finished goods increased from Sep. 2023 ($282 Mil) to Sep. 2024 ($308 Mil) and increased from Sep. 2024 ($308 Mil) to Sep. 2025 ($346 Mil).

Coloplast AS Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Inventories, Finished Goods Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 220.71 245.31 282.07 307.68 345.97

Coloplast AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 345.97 0.00 0.00
CLPBF
72GF Score
Coloplast AS CLPBF
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coloplast AS Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $0 Mil mean?
Coloplast AS (CLPBF) has a Inventories, Finished Goods of $0 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Coloplast AS and its competitors.
Is Coloplast AS's Inventories, Finished Goods too high?
Coloplast AS's current Inventories, Finished Goods is $0 Mil. Overall, Coloplast AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Inventories, Finished Goods compare to ISRG and BDX?
Coloplast AS's Inventories, Finished Goods of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Coloplast AS and its competitors. Coloplast AS's current Inventories, Finished Goods is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $128.09, compared to a current price of $60.47 — trading 52.8% below its estimated fair value. The current Inventories, Finished Goods is $0 Mil. Coloplast AS's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Inventories, Finished Goods is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (CLPBF) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of $60.47 is trading 52.8% below its estimated GF Value™ of $128.09. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for CLPBF:

  • Inventories, Finished Goods: $0 Mil
  • GF Value™: $128.09 vs. price of $60.47 (52.8% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
72GF Score

Get the complete analysis for CLPBF

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$60.47
Price
$128.09
GF Value